Navigation Links
Gateway Analytical to Exhibit Pharmaceutical Forensic Services at the American Association of Pharmaceutical Scientist Annual Meeting in San Antonio

PITTSBURGH, Nov. 8, 2013 /PRNewswire-iReach/ -- Gateway Analytical will be showcasing our pharmaceutical investigations and testing services for pharmaceutical materials characterization, at booth #4213 during 2013 AAPS Annual Meeting & Exposition in San Antonio, Texas. The conference, hosted by the American Association of Pharmaceutical Scientists (AAPS), allows thousands of members of the pharmaceutical science community to gather for the purpose of exchanging knowledge, discussing the latest research and technologies being used and networking with peers as well as other professionals from the pharmaceutical industry.

At the conference, Gateway Analytical will highlight its 20 years of experience in advanced analytical testing services for a wide range of pharmaceutical drug product types. Representatives from Gateway Analytical will discuss the lab's analytical services offerings - specifically orally inhaled and nasal products, tablets, semi-solids, transdermal drug delivery, pharmaceutical investigations, glass delamination and defect analysis, as well as their consulting services.

"We are very excited to exhibit at the AAPS conference and showcase our expertise to a large group of pharmaceutical scientists," said David Exline, Senior Vice President at Gateway Analytical.  "Our aim is to convey that at the root of our laboratory environment lies a trusted quality system. We are well versed in cGMP and Quality by Design (QbD) processes and procedures to support foreign particulate matter identifications and other pharmaceutical investigation services. Our expertise can help to guide pharmaceutical customers through tough regulatory waters as they develop products."

Gateway Analytical is a full service FDA registered and inspected laboratory with specialized expertise in state-of-the-art techniques for chemically specific particle sizing and particulate contamination identification. The lab's accreditations include cGMP-compliant, ISO 9001:2008, 21 CFR parts 210 & 211, 21 CFR part 820, and ICH Q7.  By utilizing techniques such as optical and polarized light microscopy, Raman and FTIR spectroscopy, SEM/EDS and Raman, visible fluorescence and NIR chemical imaging, Gateway Analytical's scientists are able to offer unique forensic-based-testing methods to quickly address pharmaceutical issues such as identifying when and where foreign particulate matter enter a manufacturing process, pinpointing the root cause of product failures or investigating the source of product stains or discoloration.

For more information on Gateway Analytical's pharmaceutical forensic and investigation services, contact Tracey Safran, Senior Account Manager, at or Karen Sutch, Business Development Manager, at

About Gateway Analytical

Based in Gibsonia, Pa., Gateway Analytical, LLC partners with companies in need of high-quality laboratory analysis that do not have the time, resources or capabilities for specialized, comprehensive testing. Through conventional and innovative testing methods, the company provides expert laboratory services and analytical solutions for the pharmaceutical, forensic and materials science industries.

Gateway Analytical is a subsidiary of ChemImage Corporation, a leader in chemical imaging technology and instrumentation.

About ChemImage

ChemImage Corporation, a leader in hyperspectral and Raman chemical imaging technology provides innovative instrumentation, analysis software, contract services and expert consulting to government, industrial and academic organizations. The company's proprietary, state-of-the-art imaging technology has many applications, including defense, security, pharmaceuticals, forensics and biomedical diagnostic research, which can reveal critical chemical and biological information from a variety of material systems.

ChemImage's headquarters are located in Pittsburgh, PA, where it pioneers research and development, as well as providing engineering and manufacturing which develops innovative products for the global marketplace.

Media Contact: Tifanie Tiberio, ChemImage Corp., 4122417335,

News distributed by PR Newswire iReach:

SOURCE ChemImage Corp
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cardium to Present at Sachs Associates 2012 Science, Partner, and Investment Forum: Gateway for the Global Life Sciences
2. Gateway Foundation Warns K2 is Bad News: K2 Poses Serious Health Risks
3. Vermillion to Present at the 2012 Gateway Conference on September 6
4. Three New Procedures Introduced At The Gateway Aesthetic Institute
5. Gateway Unites Medicine and Therapy to Treat Drug Addiction
6. Study Results Demonstrate Analytical Treatment Interruption to Assess Antiviral Activity of Argoss Arcelis™ Personalized Immunotherapy for Treatment of HIV Patients, AGS-004, Is Acceptable Strategy for At Least 16 Weeks
7. Sigma-Aldrich Accelerates Analytical Research and Extends Benefits of Fused-Core Particle Technology to All HPLC Users with the Launch of New Ascentis Express 5 Micron Particle by Supelco
8. Cen-Med Enterprises, Leading Supplier to the Healthcare Industry, Debuts New Technical Services Division Dedicated to Repair and Maintenance of Analytical Instruments and Lab Storage Equipment
9. Government Investments in Upgrades Sustain Laboratory Analytical Instrumentation Market in China, Finds Frost & Sullivan
10. AAIPharma Appoints Director Of Analytical Chemistry
11. AAIPharma Announces Promotion Of Dean Shirazi To EVP Of Analytical Laboratories
Post Your Comments:
(Date:11/27/2015)... , Niederlande, November 27, 2015 ... fotodynamischer Bremachlorin-Therapie bei fortgeschrittenem Krebs.   --> ... Bremachlorin-Therapie bei fortgeschrittenem Krebs.   --> ... Bremachlorin-Therapie bei fortgeschrittenem Krebs.   Clinical ... --> Clinical Cancer Research vom ...
(Date:11/26/2015)... 26, 2015 Un nuevo enfoque ... para el cáncer avanzado.   --> ... fotodinámica de Bremachlorin para el cáncer avanzado.   ... inmunoterapia con la terapia fotodinámica de Bremachlorin para el ... . --> Clinical Cancer Research . ...
(Date:11/26/2015)... , Nov. 26, 2015 Research and Markets ... "Asia Pacific Cardiac Pacemaker Market Outlook to 2019 - Rise ... the Demand " report to their offering. ... --> Boston scientific and others. ... players including Medtronic, Biotronik, Boston scientific ...
Breaking Medicine Technology:
(Date:11/27/2015)... (PRWEB) , ... November 28, 2015 , ... There is ... we outperform our billings from last year? , This question has not been an ... are coming to the retirement age and the younger workforce don’t share the same ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... of Toronto and the University of British Columbia suggested that laws requiring bicyclists to ... article explains that part of the reason for the controversial conclusion is that, while ...
(Date:11/27/2015)... ... ... The rapid speed at which Americans are aging is ... needed, especially with Alzheimer’s, dementia and other cognitive conditions becoming more prevalent. Health ... of this equation: 80 percent of medical care occurs in the home, by ...
(Date:11/27/2015)... ... 27, 2015 , ... An inventor, from Hopkinsville, Ky., thought ... at home, so he invented the patent-pending ELECTRONIC M.D. , The ELECTRONIC M.D. ... doing so, it could help to prevent potential overdose situations. As a result, ...
(Date:11/27/2015)... Orange County, CA (PRWEB) , ... November 27, 2015 , ... ... holiday season , The company is offering customers 10% off of their purchase of ... purchase any treatment at full price. According to a company spokesperson. “Finding lice is ...
Breaking Medicine News(10 mins):